Targeted Strategies for Today's Evolving Markets

MissionIR Blog

GeoVax Labs, Inc. (GOVX) to Present at Rodman & Renshaw’s 14th Annual Global Investment Conference

GeoVax Labs is a biotechnology company focused on the development of vaccines to prevent and fight HIV/AIDS. GeoVax vaccines are designed to be used in uninfected people to prevent acquisition of HIV-1 and to limit the progression to AIDS if a person becomes infected. GeoVax vaccines are additionally being tested as a therapeutic treatment for those already infected with the HIV-1 virus. For more information, visit the company’s Web site at www.geovax.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below:

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research and sales and trading services to institutional investors. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.
This entry was posted in Rodman and Renshaw Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *